Among the various genetic aberrations associated with NSCLC, mutations in the Epidermal Growth Factor Receptor (EGFR) gene are of particular clinical importance, especially due to their implications for targeted therapies (2). Here, EGFR is linked to non-small cell lung carcinoma.